HPM Partners »

Lucid Diagnostics shares owned by HPM Partners

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $31k 29k 1.07

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Lucid Diagnostics

Alyeska Investment Group
BlackRock
Vanguard Capital Management
Two Seas Capital
Masters Capital Mgmt
Standard Life Aberdeen
Geode Capital Management
First Manhattan
Wells Fargo & Company
Russell Investments
State Street Corporation
Northern Trust
Perkins Capital Management
Vanguard Fiduciary Trust
Vanguard Portfolio Management

View all funds holding Lucid Diagnostics